Ian R Buxton

Title: Innovations and Contributions of Ian R. Buxton

Introduction

Ian R. Buxton is a prominent inventor based in Cambridge, GB, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has dedicated his career to developing innovative solutions aimed at improving medication safety and efficacy.

Latest Patents

One of his latest patents is titled "Pharmaceutical iodine compositions with reduced irritancy." This stable pharmaceutical composition includes an aqueous solution of elemental iodine combined with an organic substance that reacts with iodine, effectively controlling iodine loss by providing a source of iodate ions in specified weight percentages. Another noteworthy patent is the "Pharmaceutical spheroid formulation," which discloses a controlled release composition that incorporates spheroid cores of diltiazem or its pharmaceutically acceptable salts. This invention focuses on improving the release mechanism by using microcrystalline cellulose as a spheronizing agent and ethylcellulose as a preferred release coating.

Career Highlights

Ian's innovative work has primarily been carried out at Euro-Celtique S.A., a company that focuses on the advancement of pharmaceutical products. His research and patent filings reflect a deep commitment to enhancing the safety and effectiveness of medicinal treatments through innovative compositions and formulations.

Collaborations

Throughout his career, Ian has collaborated with talented professionals, including Sandra Therese Malkowska and Derek Allan Prater. Their collective expertise has undoubtedly contributed to the successful development of Ian’s inventive work.

Conclusion

Ian R. Buxton's contributions to the field of pharmaceutical innovations are noteworthy. With his seven patents, he continues to influence the industry, emphasizing the importance of creating safe and effective pharmaceutical compositions. His ongoing work at Euro-Celtique S.A. and collaborations with esteemed colleagues showcase his commitment to advancing healthcare through innovation.